Yutaka Hattori

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Newly Diagnosed

Multiple Myeloma

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maiko Matsushita, Sho Kashiwazaki, Satoshi Kamiko, Michio Kobori, Makoto Osada, Hisako Kunieda, Maki Hirao, Daiju Ichikawa, Yutaka Hattori
Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Mikio Okayama, Kota Fujimori, Mariko Sato, Koichi Samata, Koki Kurita, Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, Hisako Kunieda, Kohei Yamazaki, Yutaka Hattori
GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase. Cancer medicine (2023)
Tomofumi Yamamoto, Jun Nakayama, Yusuke Yamamoto, Masahiko Kuroda, Yutaka Hattori, Takahiro Ochiya
SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma. Blood advances 6 (8) (2022)
Yutaka Hattori, Takumi Futo, Ryo Uozaki, Daiju Ichikawa, Takashi Yamaguchi, Tomofumi Yamamoto, Maiko Matsushita, Maki Hirao
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells. International journal of hematology 115 (4) (2022)
Maki Hirao, Kohei Yamazaki, Kentaro Watanabe, Kiyoshi Mukai, Shigemichi Hirose, Makoto Osada, Yuiko Tsukada, Hisako Kunieda, Ryunosuke Denda, Takahide Kikuchi, Hiroki Sugimori, Shinichiro Okamoto, Yutaka Hattori
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease. F1000Research 11 (2022)